Horizon Blue Cross and Blue Shield of New Jersey policies, page 15

Search Horizon Blue Cross and Blue Shield of New Jersey's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

834 public policies Substrate tracks for Horizon Blue Cross and Blue Shield of New Jersey, by title.

Horizon Blue Cross and Blue Shield of New Jersey policies
PolicyDetailsCodesSource
RhinoplastyCommercial, Medicaid4Original policy ↗
Risk-Reducing MastectomyCommercial, Medicaid—Original policy ↗
Risk-Reducing Salpingo-OophorectomyCommercial, Medicaid—Original policy ↗
Rituximab (Rituxan), Rituximab-abbs (Truxima), Rituximab-pvvr (Ruxience), and Rituximab/hyaluronidase (Rituxan Hycela)Commercial—Original policy ↗
Romiplostim (Nplate)Commercial—Original policy ↗
Romosozumab-aqqg (Evenity)Commercial—Original policy ↗
Sacituzumab govitecan-hziy (Trodelvy)Commercial—Original policy ↗
Sacral Nerve Neuromodulation/StimulationCommercial, Medicaid—Original policy ↗
Sacroiliac Joint ArthrographyCommercial—Original policy ↗
Sacroiliac Joint Fusion/StabilizationCommercial—Original policy ↗
Sacroiliac Joint InjectionsCMM-203 · Commercial, Medicaid3Original policy ↗
Salivary Hormone Testing for MenopauseCommercial, Medicaid1Original policy ↗
Sandostatin, Sandostatin LAR depot (Octreotide), Somatuline Depo (lanreotide), Signifor LAR (pasireotide)Commercial—Original policy ↗
Seat Lift MechanismsCommercial, Medicaid9Original policy ↗
Sebelipase alfa (Kanuma)Commercial—Original policy ↗
Sensory Integration Therapy and Auditory Integration TherapyCommercial, Medicaid—Original policy ↗
SeptoplastyCommercial, Medicaid—Original policy ↗
Serologic Genetic and Molecular Screening for Colorectal CancerCommercial, Medicaid—Original policy ↗
Serologic Markers for the Diagnosis of Irritable Bowel SyndromeCommercial, Medicaid—Original policy ↗
Serum Biomarker Human Epididymis Protein 4 (HE4)Commercial—Original policy ↗
Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue DiseasesCommercial—Original policy ↗
Serum Biomarker Tests for Multiple SclerosisCommercial, Medicaid—Original policy ↗
Serum Holotranscobalamin as a Marker of Vitamin B12 (Cobalamin) StatusCommercial, Medicaid—Original policy ↗
Shoulder ResurfacingCommercial, Medicaid—Original policy ↗
Signal-Averaged Electrocardiography (SAECG)Commercial, Medicaid—Original policy ↗
Siltuximab (Sylvant)Commercial—Original policy ↗
Sipuleucel-T (Provenge®)Commercial—Original policy ↗
Site of Service DifferentialEffective Oct 20, 2021 · Commercial, Medicaid2Original policy ↗
Site of Service for Administration for Infusion and Injectable Prescription MedicationsCommercial, Medicaid—Original policy ↗
Site of Service for Elective Surgical ProceduresEffective Jan 2, 2025 · Commercial, Medicaid—Original policy ↗
Skin Contact Monochromatic Infrared Energy as a Technique to Treat Cutaneous Ulcers, Diabetic Neuropathy, and Miscellaneous Musculoskeletal ConditionsCommercial, Medicaid—Original policy ↗
Small Bowel/Liver and Multivisceral TransplantCommercial, Medicaid—Original policy ↗
Smoking CessationEffective Sep 26, 2019 · Commercial8Original policy ↗
Sodium Hyaluronate InjectionsCommercial15Original policy ↗
Solesta (Dextranomer and Sodium Hyaluronate Gel for Submucosal Injection)Commercial—Original policy ↗
Speech Generating DevicesCommercial, Medicaid—Original policy ↗
Speech Therapy in the Home and Outpatient FacilityCommercial, Medicaid—Original policy ↗
Sphenopalatine Ganglion Block for HeadacheCommercial, Medicaid—Original policy ↗
Spinal Cord and Implantable Peripheral Nerve StimulatorsCMM-211 · Commercial, Medicaid11Original policy ↗
Status N CodesEffective Oct 19, 2016 · Commercial, Medicaid—Original policy ↗
Stem-Cell Therapy for Peripheral Arterial DiseaseCommercial, Medicaid—Original policy ↗
Steroid-Eluting Sinus StentsCommercial—Original policy ↗
Strontium-89 Chloride (Metastron)—Original policy ↗
Subtalar ArthroereisisCommercial—Original policy ↗
Suprachoroidal Delivery of Pharmacologic AgentsCommercial, Medicaid—Original policy ↗
Surgery for Groin Pain in AthletesCommercial—Original policy ↗
Surgery for Morbid ObesityCommercial, Medicaid8Original policy ↗
Surgical Deactivation of Headache Trigger SitesCommercial—Original policy ↗
Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary DysmenorrheaCommercial, Medicaid—Original policy ↗
Surgical Treatment of HyperhidrosisCommercial, Medicaid—Original policy ↗

Back to Horizon Blue Cross and Blue Shield of New Jersey

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.